↓ Skip to main content

Preamble to the 2015 SITC immunotherapy biomarkers taskforce

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
9 tweeters

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
Published in
Journal for Immunotherapy of Cancer, March 2015
DOI 10.1186/s40425-015-0052-6
Pubmed ID
Authors

Lisa H Butterfield, Mary L Disis, Bernard A Fox, Samir N Khleif, Francesco M Marincola

Abstract

The Society for Immunotherapy of Cancer (SITC) has regularly hosted workshops and working groups focused on immunologic monitoring and immune biomarkers. Due to advances in cancer immunotherapy, including positive results from clinical trials testing new agents and combinations, emerging new technologies for measuring aspects of immunity, and novel candidate biomarkers from early phase trials, the SITC Immune Biomarkers Taskforce has reconvened to review the state of the art, identify current hurdles to further success and to make recommendations to the field. Topics being addressed by individual working groups include: (1) validation of candidate biomarkers, (2) identification of the most promising technologies, (3) testing of high throughput immune signatures and (4) investigation of the pre-treatment tumor microenvironment. Resultant recommendations will be published in JITC.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 52%
Student > Ph. D. Student 2 9%
Student > Doctoral Student 1 4%
Other 1 4%
Professor 1 4%
Other 0 0%
Unknown 6 26%
Readers by discipline Count As %
Immunology and Microbiology 3 13%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Chemistry 2 9%
Agricultural and Biological Sciences 2 9%
Other 3 13%
Unknown 8 35%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2015.
All research outputs
#1,443,219
of 8,605,940 outputs
Outputs from Journal for Immunotherapy of Cancer
#99
of 342 outputs
Outputs of similar age
#44,261
of 203,816 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#3
of 8 outputs
Altmetric has tracked 8,605,940 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 342 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,816 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.